{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:59:06Z","timestamp":1760425146919,"version":"3.30.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T00:00:00Z","timestamp":1344470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T00:00:00Z","timestamp":1344470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11882-012-0290-3","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T18:38:16Z","timestamp":1344451096000},"page":"402-412","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Therapeutic Strategies for Harnessing Human Eosinophils in Allergic Inflammation, Hypereosinophilic Disorders, and Cancer"],"prefix":"10.1007","volume":"12","author":[{"given":"Zhaleh J.","family":"Amini-Vaughan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Martinez-Moczygemba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Huston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,9]]},"reference":[{"key":"290_CR1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.immunol.24.021605.090720","volume":"24","author":"ME Rothenberg","year":"2006","unstructured":"Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol. 2006;24:147\u201374.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"290_CR2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2222.2008.02958.x","volume":"38","author":"SP Hogan","year":"2008","unstructured":"Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy. 2008;38(5):709\u201350.","journal-title":"Clin Exp Allergy"},{"key":"290_CR3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-2776(08)01003-1","volume":"101","author":"C Blanchard","year":"2009","unstructured":"Blanchard C, Rothenberg ME. Biology of the eosinophil. Adv Immunol. 2009;101:81\u2013121.","journal-title":"Adv Immunol"},{"issue":"1","key":"290_CR4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00441-010-1049-6","volume":"343","author":"R Shamri","year":"2011","unstructured":"\u2022 Shamri R, Xenakis JJ, Spencer LA. Eosinophils in innate immunity: an evolving story. Cell Tissue Res. 2011;343(1):57\u201383. This comprehensive review of eosinophil biology describes the complex role of eosinophils in innate immunity.","journal-title":"Cell Tissue Res"},{"key":"290_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev.me.44.020193.000505","volume":"44","author":"GJ Gleich","year":"1993","unstructured":"Gleich GJ, Adolphson CR, Leiferman KM. The biology of the eosinophilic leukocyte. Annu Rev Med. 1993;44:85\u2013101.","journal-title":"Annu Rev Med"},{"key":"290_CR6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1146\/annurev.bi.59.070190.004031","volume":"59","author":"KI Arai","year":"1990","unstructured":"Arai KI, Lee F, Miyajima A, et al. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59:783\u2013836.","journal-title":"Annu Rev Biochem"},{"key":"290_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.iy.10.040192.001455","volume":"10","author":"AT Miyajima","year":"1992","unstructured":"Miyajima AT, Kitamura N, Harada T, Yokota T, Arai K. Cytokine receptors and signal transduction. Annu Rev Immunol. 1992;10:295\u2013331.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"290_CR8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cellimm.2003.10.001","volume":"225","author":"A Komiya","year":"2003","unstructured":"Komiya A, Nagase H, Yamada H, et al. Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells. Cell Immunol. 2003;225(2):91\u2013100.","journal-title":"Cell Immunol"},{"issue":"1","key":"290_CR9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568010033344480","volume":"2","author":"P Amerio","year":"2003","unstructured":"Amerio P, Frezzolini A, Feliciani C, et al. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Curr Drug Targets Inflamm Allergy. 2003;2(1):81\u201394.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"290_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1165\/rcmb.2010-0027TR","volume":"44","author":"R Halwani","year":"2011","unstructured":"Halwani R, Al-Muhsen S, Al-Jahdali H, Hamid Q. Role of transforming growth factor-\u03b2 in airway remodeling in asthma. Am J Respir Cell Mol Biol. 2011;44:127\u201333.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"290_CR11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/156652408785160943","volume":"8","author":"B Moore","year":"2008","unstructured":"Moore B, Murphy RF, Agrawal DK. Interaction of tgf-beta with immune cells in airway disease. Curr Mol Med. 2008;8(5):427\u201336.","journal-title":"Curr Mol Med"},{"issue":"1","key":"290_CR12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaci.2003.10.050","volume":"113","author":"AD Klion","year":"2004","unstructured":"Klion AD, Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol. 2004;113(1):30\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"290_CR13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.cji.0000211324.53396.f6","volume":"30","author":"R Lotfi","year":"2007","unstructured":"Lotfi R, Lee JJ, Lotze MT. Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors. J Immunother. 2007;30:16\u201328.","journal-title":"J Immunother"},{"issue":"Suppl","key":"290_CR14","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.3347\/kjp.2009.47.S.S125","volume":"47","author":"MH Shin","year":"2009","unstructured":"Shin MH, Lee YA, Min DY. Eosinophil-mediated tissue inflammatory responses in helminth infection. Korean J Parasitol. 2009;47(Suppl):S125\u201331.","journal-title":"Korean J Parasitol"},{"issue":"1","key":"290_CR15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2567.2012.03556.x","volume":"136","author":"AM Kvarnhammar","year":"2012","unstructured":"Kvarnhammar AM, Cardell LO. Pattern recognition receptors in human eosinophils. Immunology. 2012;136(1):11\u201320.","journal-title":"Immunology"},{"key":"290_CR16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1146\/annurev.immunol.22.012703.104716","volume":"22","author":"L Cohn","year":"2004","unstructured":"Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004;22:789\u2013815.","journal-title":"Annu Rev Immunol"},{"key":"290_CR17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1600-065X.2001.790117.x","volume":"179","author":"PS Foster","year":"2001","unstructured":"Foster PS, Mould AW, Yang M, et al. Elemental Signals regulating eosinophil accumulation in the lung. Immunol Rev. 2001;179:173\u201381.","journal-title":"Immunol Rev"},{"issue":"5691","key":"290_CR18","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1126\/science.1099472","volume":"305","author":"JJ Lee","year":"2004","unstructured":"Lee JJ, Dimina D, Macias MP, et al. Defining a link with asthma in mice congenitally deficient in eosinophils. Science. 2004;305(5691):1773\u201376.","journal-title":"Science"},{"issue":"5691","key":"290_CR19","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1126\/science.1100283","volume":"305","author":"AA Humbles","year":"2004","unstructured":"Humbles AA, Lloyd CM, McMillan SJ, et al. A critical role for eosinophils in allergic airway remodeling. Science. 2004;305(5691):1776\u201379.","journal-title":"Science"},{"key":"290_CR20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1172\/JCI19133","volume":"113","author":"JY Cho","year":"2004","unstructured":"Cho JY, Miller M, Baek KJ, et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest. 2004;113:551\u201360.","journal-title":"J Clin Invest"},{"key":"290_CR21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","volume":"326","author":"DS Robinson","year":"1992","unstructured":"Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like brochoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992;326:298\u2013304.","journal-title":"N Engl J Med"},{"key":"290_CR22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/ajrccm.155.3.9117011","volume":"155","author":"E Hamelmann","year":"1997","unstructured":"Hamelmann E, Oshiba A, Loader J, et al. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am J Respir Crit Care Med. 1997;155:819\u201325.","journal-title":"Am J Respir Crit Care Med"},{"key":"290_CR23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.183.1.195","volume":"183","author":"PS Foster","year":"1996","unstructured":"Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med. 1996;183:195\u2013201.","journal-title":"J Exp Med"},{"key":"290_CR24","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1084\/jem.185.12.2143","volume":"185","author":"JJ Lee","year":"1997","unstructured":"Lee JJ, McGarry MP, Farmer SC, et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med. 1997;185:2143\u201356.","journal-title":"J Exp Med"},{"key":"290_CR25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.med.60.062107.090340","volume":"60","author":"AD Klion","year":"2009","unstructured":"Klion AD. Hypereosinophilic syndrome: current approach to diagnosis and treatment. Annu Rev Med. 2009;60:293\u2013306.","journal-title":"Annu Rev Med"},{"issue":"1","key":"290_CR26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2010.03.042","volume":"126","author":"HU Simon","year":"2010","unstructured":"\u2022 Simon HU, Rothenberg ME, Bochner BS, et al. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol. 2010;126(1):45\u20139. This article discusses the shortcomings of the old HES definition and proposes new considerations for HES classification.","journal-title":"J Allergy Clin Immunol"},{"key":"290_CR27","doi-asserted-by":"crossref","unstructured":"\u2022 Valent P, Klion AD, Horny HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012; [Epub ahead of print]. An expert group of immunology, allergy, hematology, and pathology experts propose updated and refined criteria for the classification of eosinophilic disorders and related syndromes in this manuscript.","DOI":"10.1016\/j.jaci.2012.02.019"},{"issue":"1","key":"290_CR28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11882-006-0013-8","volume":"6","author":"SP Hogan","year":"2006","unstructured":"Hogan SP, Rothenberg ME. Eosinophil function in eosinophil-associated gastrointestinal disorders. Curr Allergy Asthma Rep. 2006;6(1):65\u201371.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"290_CR29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.coi.2008.07.010","volume":"20","author":"CW DeBrosse","year":"2008","unstructured":"DeBrosse CW, Rothenberg ME. Allergy and eosinophil-associated gastrointestinal disorders (EGID). Curr Opin Immunol. 2008;20(6):703\u20138.","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"290_CR30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MOG.0b013e328352b5ef","volume":"28","author":"ES Dellon","year":"2012","unstructured":"Dellon ES. Eosinophilic esophagitis: diagnostic tests and criteria. Curr Opin Gastroenterol. 2012;28(4):382\u20138.","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"290_CR31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI10224","volume":"107","author":"A Mishra","year":"2001","unstructured":"Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107(1):83\u201390.","journal-title":"J Clin Invest"},{"issue":"1","key":"290_CR32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/BOR.0b013e3280119854","volume":"19","author":"C Pagnoux","year":"2007","unstructured":"Pagnoux C, Guilpain P, Guillevin L. Churg-Strauss syndrome. Curr Opin Rheumatol. 2007;19(1):25\u201332.","journal-title":"Curr Opin Rheumatol"},{"key":"290_CR33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.rdc.2010.05.003","volume":"36","author":"C Baldini","year":"2010","unstructured":"Baldini C, Talarico R, Della Rossa A, Bombardieri S. Clinical manifestations and treatment of Churg-Strauss syndrome. Rheum Dis Clin North Am. 2010;36:527\u201343.","journal-title":"Rheum Dis Clin North Am"},{"key":"290_CR34","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jaci.2005.09.009","volume":"116","author":"MS Blaiss","year":"2005","unstructured":"Blaiss MS. Expanding the evidence base for the medical treatment of nasal polyposis. J Allergy Clin Immunol. 2005;116:1272\u20134.","journal-title":"J Allergy Clin Immunol"},{"issue":"7395","key":"290_CR35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nature11047","volume":"484","author":"NW Palm","year":"2012","unstructured":"Palm NW, Rosenstein RK, Medzhitov R. Allergic host defences. Nature. 2012;484(7395):465\u201372.","journal-title":"Nature"},{"issue":"4","key":"290_CR36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2222.2010.03484.x","volume":"40","author":"JJ Lee","year":"2010","unstructured":"\u2022 Lee JJ, Jacobsen EA, McGarry MP, Schleimer RP, Lee NA. Eosinophils in health and disease: the LIAR hypothesis. Clin Exp Allergy. 2010;40(4):563\u201375. This provocative review challenges current dogma classifying eosinophils as simply end-stage effector cells and proposes a novel, counter concept in which accumulating tissue eosinophils are actually regulators of Local Immunity And\/or Remodeling\/Repair in both health and disease - the LIAR hypothesis.","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"290_CR37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/1568010033484214","volume":"2","author":"J Mattes","year":"2003","unstructured":"Mattes J, Foster PS. Regulation of eosinophil migration and Th2 cell function by IL-5 and eotaxin. Curr Drug Targets Inflamm Allergy. 2003;2(2):169\u201374.","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"290_CR38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0167-5699(90)90139-Z","volume":"10","author":"JF Bazan","year":"1990","unstructured":"Bazan JF. Haemopoetic receptors and helical cytokines. Immunol Today. 1990;10:350\u201354.","journal-title":"Immunol Today"},{"key":"290_CR39","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4049\/jimmunol.156.3.1030","volume":"156","author":"RR Dickason","year":"1996","unstructured":"Dickason RR, Huston MM, Huston DP. Delineation of IL-5 domains, predicted to engage the IL-5 receptor complex. J Immunol. 1996;156:1030\u20137.","journal-title":"J Immunol"},{"issue":"6","key":"290_CR40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1107\/S1744309106016812","volume":"62","author":"PD Carr","year":"2006","unstructured":"Carr PD, Conlan F, Ford S, Ollis DL, Young IG. An improved resolution structure of the human \u03b2 common receptor involved in IL-3, IL-5 and GM-CSF signaling which gives better definition of the high-affinity binding epitope. Acta Crystallogr F Struct Biol Crystallogr Commun. 2006;62(6):509\u201313.","journal-title":"Acta Crystallogr F Struct Biol Crystallogr Commun"},{"key":"290_CR41","doi-asserted-by":"crossref","unstructured":"\u2022 Patino E, Kotzsch A, Saremba S, et al. Structure analysis of the IL-5 ligand-receptor complex reveals a wrench-like architecture for IL-5R\u03b1. Structure 2011, 19(12):1864-75. This seminal study reports the crystal structure of IL-5 bound to the IL-5Ra extracellular domain. Structural analysis of the IL-5Ra reveals a wrench-like architecture that is likely preferred.","DOI":"10.1016\/j.str.2011.08.015"},{"issue":"3","key":"290_CR42","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cell.2008.05.053","volume":"134","author":"G Hansen","year":"2008","unstructured":"Hansen G, Hercus TR, McClure BJ, et al. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell. 2008;134(3):496\u2013507.","journal-title":"Cell"},{"issue":"6","key":"290_CR43","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","volume":"125","author":"R Kolbeck","year":"2010","unstructured":"Kolbeck R, Kozhich A, Koike M, et al. MEDI-563, a humanized anti-IL-5 receptor \u03b1 mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. J Allergy Clin Immunol. 2010;125(6):1344\u201353.","journal-title":"J Allergy Clin Immunol"},{"key":"290_CR44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jaci.2003.08.015","volume":"112","author":"M Martinez-Moczygemba","year":"2003","unstructured":"Martinez-Moczygemba M, Huston DP. Biology of Common \u03b2 receptor-signalling cytokine: IL-3, IL-5 and GM-CSF. J Allergy Clin Immunol. 2003;112:653\u201365.","journal-title":"J Allergy Clin Immunol"},{"key":"290_CR45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-6749(99)70138-7","volume":"104","author":"FR Shardonofsky","year":"1999","unstructured":"Shardonofsky FR, Venzor 3rd J, Barrios R, et al. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma. J Allergy Clin Immunol. 1999;104:215\u201321.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"290_CR46","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/intimm\/11.12.1935","volume":"11","author":"JI Zhang","year":"1999","unstructured":"Zhang JI, Kuvelkar R, Murgolo J, et al. Mapping and characterization of the epitopes of Sch 55700, a humanized mAb, that inhibits human IL-5. Int Immunol. 1999;11(12):1935\u201343.","journal-title":"Int Immunol"},{"issue":"2","key":"290_CR47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mai.2001.116576","volume":"108","author":"TK Hart","year":"2001","unstructured":"Hart TK, Cook RM, Zia-Amirhosseini P, et al. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys. J Allergy Clinical Immunol. 2001;108(2):250\u20137.","journal-title":"J Allergy Clinical Immunol"},{"key":"290_CR48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/S0074-02761997000800011","volume":"92","author":"RW Egan","year":"1997","unstructured":"Egan RW, Athwahl D, Chou CC, et al. Pulmonary biology of anti-interleukin 5 antibodies. Mem Inst Oswaldo Cruz. 1997;92:69\u201373.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"11","key":"290_CR49","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","volume":"176","author":"P Flood-Page","year":"2007","unstructured":"Flood-Page P, Swenson C, Faiferman I, et al. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med. 2007;176(11):1062\u201371.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9248","key":"290_CR50","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","volume":"356","author":"MJ Leckie","year":"2000","unstructured":"Leckie MJ, ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2000;356(9248):2144\u20138.","journal-title":"Lancet"},{"key":"290_CR51","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","volume":"360","author":"P Nair","year":"2009","unstructured":"Nair P, Pizzichini MMM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. NEJM. 2009;360:985\u201393.","journal-title":"NEJM"},{"key":"290_CR52","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","volume":"360","author":"P Haldar","year":"2009","unstructured":"Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. NEJM. 2009;360:973\u201384.","journal-title":"NEJM"},{"issue":"5","key":"290_CR53","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","volume":"128","author":"P Gevaert","year":"2011","unstructured":"Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128(5):989\u201395.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"290_CR54","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","volume":"358","author":"ME Rothenberg","year":"2008","unstructured":"Rothenberg ME, Klion AD, Roufosse FE, et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. NEJM. 2008;358(12):1215\u201328.","journal-title":"NEJM"},{"issue":"4","key":"290_CR55","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaci.2010.06.049","volume":"126","author":"F Roufosse","year":"2010","unstructured":"Roufosse F, de Lavareille A, Schanden\u00e9 L, et al. Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome. J Allergy Clin Immunol. 2010;126(4):826\u201335.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"290_CR56","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","volume":"118","author":"ML Stein","year":"2006","unstructured":"Stein ML, Collins MH, Villanueva JM, et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy CLin Immunol. 2006;118(6):1312\u20139.","journal-title":"J Allergy CLin Immunol"},{"key":"290_CR57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","volume":"59","author":"A Straumann","year":"2010","unstructured":"Straumann A, Conus S, Grzonka P, et al. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomized, placebo-controlled, double-blind trial. Gut. 2010;59:21\u201330.","journal-title":"Gut"},{"issue":"5","key":"290_CR58","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","volume":"141","author":"AH Assa\u2019ad","year":"2011","unstructured":"Assa\u2019ad AH, Gupta SK, Collins MH, et al. An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 2011;141(5):1593\u2013604.","journal-title":"Gastroenterology"},{"key":"290_CR59","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaci.2009.10.014","volume":"125","author":"JE Kahn","year":"2010","unstructured":"Kahn JE, Grandpeix-Guyodo C, Marroun I, et al. Sustained response to mepolizumab in refractory Churg-Strauss syndrome. J Allergy Clin Immunol. 2010;125:267\u201370.","journal-title":"J Allergy Clin Immunol"},{"key":"290_CR60","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","volume":"125","author":"S Kim","year":"2010","unstructured":"Kim S, Marigowda G, Oren E, Israel E, Wechsler M. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome. J Allergy Clin Immunol. 2010;125:1336\u201343.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"290_CR61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","volume":"60","author":"JM Oldhoff","year":"2005","unstructured":"Oldhoff JM, Darsow U, Werfel T, et al. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy. 2005;60(5):693\u20136.","journal-title":"Allergy"},{"key":"290_CR62","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000095299","volume":"141","author":"JM Oldhoff","year":"2006","unstructured":"Oldhoff JM, Darsow U, Werfel T, et al. No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients. Int Arch Allergy Immunol. 2006;141:290\u20134.","journal-title":"Int Arch Allergy Immunol"},{"issue":"12","key":"290_CR63","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1164\/rccm.200206-525OC","volume":"167","author":"JC Kips","year":"2003","unstructured":"Kips JC, O\u2019Conner BJ, Langley SJ, Woodcock A. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: A pilot study. Am J Resp Crit Med. 2003;167(12):1655\u201359.","journal-title":"Am J Resp Crit Med"},{"key":"290_CR64","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1164\/rccm.201103-0396OC","volume":"184","author":"M Castro","year":"2011","unstructured":"Castro M, Mathur S, Hargreave F, et al. Reslizumab for poorly controlled, eosinophilic asthma: A randomized, placebo controlled study. Am J Resp Crit Med. 2011;184:1125\u201332.","journal-title":"Am J Resp Crit Med"},{"key":"290_CR65","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/blood-2003-10-3620","volume":"103","author":"AD Klion","year":"2004","unstructured":"Klion AD, Law MA, Noel P, et al. Safety and efficacy of the monoclonal anti-interleukin-% antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood. 2004;103:2939\u201341.","journal-title":"Blood"},{"issue":"2","key":"290_CR66","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaci.2011.11.044","volume":"129","author":"JM Spergel","year":"2012","unstructured":"Spergel JM, Rothenberg ME, Collins MH, et al. Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2012;129(2):456\u201363.","journal-title":"J Allergy Clin Immunol"},{"key":"290_CR67","unstructured":"NIAID. A randomized, placebo-controlled, double-blind pilot study of single-dose humanized anti-IL5 antibody (reslizumab) for the reduction of eosinophilia following diethylcarbamazine treatment of Loa Loa infection. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000- [cited 2012 May 17]. Available from: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01111305?term=reslizumab&rank=9 NLM Identifier: NCT01111305."},{"issue":"2","key":"290_CR68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1432-1033.1994.00635.x","volume":"225","author":"R Devos","year":"1994","unstructured":"Devos R, Guisez Y, Plaetinck G, et al. Covalent modification of the interleukin-5 receptor by isothiazolones leads to inhibition of the binding of interleukin-5. Eur J Biochem. 1994;225(2):635\u201340.","journal-title":"Eur J Biochem"},{"key":"290_CR69","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jaci.2010.04.005","volume":"125","author":"WW Busse","year":"2010","unstructured":"Busse WW, Katial R, Gossage D, et al. Safety profile, pharmacokinetics, and biologic activity of MEDI-563, and anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma. J Allergy Clin Immunol. 2010;125:1237\u201344.","journal-title":"J Allergy Clin Immunol"},{"key":"290_CR70","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1398-9995.2011.02638.x","volume":"66","author":"GM Gauvreau","year":"2011","unstructured":"Gauvreau GM, Pageau R, Seguin R, et al. Dose\u2013response effects of TPI ASM8 in asthmatics after allergen. Allergy. 2011;66:1242\u20138.","journal-title":"Allergy"},{"key":"290_CR71","unstructured":"MedImmune LLC. A Study to Evaluate the Effectiveness of a Drug (MEDI-563) in Subjects With Chronic Obstructive Pulmonary Disease (COPD). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000- [cited 2012 May 17]. Available from: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01227278?term=MEDI-563&rank=5 NLM Identifier: NCT01227278."},{"key":"290_CR72","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.4049\/jimmunol.180.2.1199","volume":"180","author":"KL Asquith","year":"2008","unstructured":"Asquith KL, Ramshaw HS, Hansbro PM, et al. The IL-3\/IL-5\/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation. J Immunol. 2008;180:1199\u2013206.","journal-title":"J Immunol"},{"key":"290_CR73","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11882-010-0134-y","volume":"10","author":"M Martinez-Moczygemba","year":"2010","unstructured":"Martinez-Moczygemba M, Huston DP. Immune dysregulation in the pathogenesis of pulmonary alveolar proteinosis. Cur Allergy Asthma Rep. 2010;10:320\u20135.","journal-title":"Cur Allergy Asthma Rep"},{"issue":"2","key":"290_CR74","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1365-2559.2002.01437.x","volume":"41","author":"RG Dorta","year":"2002","unstructured":"Dorta RG, Landman G, Kowalski LP, et al. Tumour-associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas. Histopathology. 2002;41(2):152\u20137.","journal-title":"Histopathology"},{"key":"290_CR75","first-page":"2997","volume":"43","author":"TP Pretlow","year":"1983","unstructured":"Pretlow TP, Keith EF, Cryar AK, et al. Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer Res. 1983;43:2997\u20133000.","journal-title":"Cancer Res"},{"key":"290_CR76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/019459989210600124","volume":"106","author":"MM Goldsmith","year":"1992","unstructured":"Goldsmith MM, Belchis DA, Cresson DH, MerrittWD III, Askin FB. The importance of the eosinophil in head and neck cancer. Otolaryngol Head Neck Surg. 1992;106:27\u201333.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"290_CR77","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/1097-0142(19830701)52:1<126::AID-CNCR2820520123>3.0.CO;2-Y","volume":"52","author":"HE Ownby","year":"1983","unstructured":"Ownby HE, Roi LD, Isenberg RR, Brennan MJ. Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer. 1983;52:126\u201330.","journal-title":"Cancer"},{"issue":"3","key":"290_CR78","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<436::AID-CNCR3>3.0.CO;2-I","volume":"77","author":"SE Leighton","year":"1996","unstructured":"Leighton SE, Teo JG, Leung SF, et al. Prevalence and prognostic significance of tumor-associated tissue eosinophilia in nasopharyngeal carcinoma. Cancer. 1996;77(3):436\u201340.","journal-title":"Cancer"},{"key":"290_CR79","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1544::AID-CNCR7>3.0.CO;2-S","volume":"88","author":"MJ Fernandez-Acenero","year":"2000","unstructured":"Fernandez-Acenero MJ, Galindo-Gallego M, Sanz J, Aljama A. Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer. 2000;88:1544\u20138.","journal-title":"Cancer"},{"key":"290_CR80","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/1097-0142(19860915)58:6<1321::AID-CNCR2820580623>3.0.CO;2-O","volume":"58","author":"K Iwasaki","year":"1986","unstructured":"Iwasaki K, Torisu M, Fujimura T. Malignant tumor and eosinophils. I. Prognostic significance in gastric cancer. Cancer. 1986;58:1321\u20137.","journal-title":"Cancer"},{"key":"290_CR81","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/gyno.1999.5431","volume":"74","author":"WJ van Driel","year":"1999","unstructured":"van Driel WJ, Kievit-Tyson P, van den Broek, et al. Presence of an eosinophilic infiltrate in cervical squamous carcinoma results from a type 2 immune response. Gynecol Oncol. 1999;74:188\u201395.","journal-title":"Gynecol Oncol"},{"key":"290_CR82","first-page":"1419","volume":"26","author":"S Ishibashi","year":"2006","unstructured":"Ishibashi S, Ohashi Y, Suzuki T, et al. Tumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma. Anticancer Res. 2006;26:1419\u201324.","journal-title":"Anticancer Res"},{"key":"290_CR83","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S1368-8375(99)00023-8","volume":"35","author":"DTW Wong","year":"1999","unstructured":"Wong DTW, Bowen SM, Elovic A, Gallagher GT, Weller PF. Eosinophil ablation and tumor development. Oral Oncol. 1999;35:496\u2013501.","journal-title":"Oral Oncol"},{"issue":"1","key":"290_CR84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S, Martinez FO. Alternative activation of macrophages: mechanisms and functions. Nat Rev Immunol. 2003;3(1):23\u20135.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"290_CR85","first-page":"408","volume":"108","author":"A Sica","year":"2006","unstructured":"Sica A, Mantovani A. Macrophage diversity and polarization: in vivo veritas. J Am Soc Hemat. 2006;108(2):408\u20139.","journal-title":"J Am Soc Hemat"},{"key":"290_CR86","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2444","volume":"8","author":"C Murdoch","year":"2008","unstructured":"Murdoch C, Muthana M, Coffelt SB, Lewis CE. The role of myeloid cells in tumour angiogenesis. Nature Rev Cancer. 2008;8:618\u201331.","journal-title":"Nature Rev Cancer"},{"key":"290_CR87","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.biocel.2004.09.001","volume":"37","author":"I Puxeddu","year":"2005","unstructured":"Puxeddu I, Alian A, Piliponsky AM, et al. Human peripheral blood eosinophils induce angiogenesis. Int J Biochem Cell Biol. 2005;37:628\u201336.","journal-title":"Int J Biochem Cell Biol"},{"key":"290_CR88","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.172.3.673","volume":"172","author":"DT Wong","year":"1990","unstructured":"Wong DT, Weller PF, Galli SJ, et al. Human eosinophils express transforming growth factor alpha. J Exp Med. 1990;172:673\u201381.","journal-title":"J Exp Med"},{"key":"290_CR89","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1067\/mai.2001.111928","volume":"107","author":"M Hoshino","year":"2001","unstructured":"Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol. 2001;107:295\u2013301.","journal-title":"J Allergy Clin Immunol"},{"key":"290_CR90","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.174.3.745","volume":"174","author":"H Kita","year":"1991","unstructured":"Kita H, Ohnishi T, Okubo Y, et al. Granulocyte\/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med. 1991;174:745\u20138.","journal-title":"J Exp Med"},{"issue":"3","key":"290_CR91","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1165\/ajrcmb.16.3.9070604","volume":"16","author":"I Ohno","year":"1997","unstructured":"Ohno I, Ohtani H, Nitta Y, et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol. 1997;16(3):212\u20139.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"290_CR92","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.20021683","volume":"197","author":"J Mattes","year":"2003","unstructured":"Mattes J, Hulett M, Xie W, et al. Immunotherapy of cytotoxic T cell resistant tumors by T helper 2 cells: an eotaxin and STAT 6-dependent process. J Exp Med. 2003;197:387\u201393.","journal-title":"J Exp Med"},{"issue":"7","key":"290_CR93","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.4049\/jimmunol.178.7.4222","volume":"178","author":"L Simson","year":"2007","unstructured":"Simson L, Ellyard JI, Dent LA, et al. Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor surveillance. J Immunol. 2007;178(7):4222\u20139.","journal-title":"J Immunol"},{"key":"290_CR94","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1189\/jlb.0106027","volume":"9","author":"SA Cormier","year":"2006","unstructured":"Cormier SA, Taranova AG, Bedient C, et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol. 2006;9:1131\u20139.","journal-title":"J Leukoc Biol"},{"issue":"12","key":"290_CR95","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.4049\/jimmunol.1000446","volume":"185","author":"F Legrand","year":"2010","unstructured":"\u2022 Legrand F, Driss V, Delbeke M, et al. Human Eosinophils exert TNFa and Granzyme A-mediated tumorcidal activity toward colon carcinoma cells. J Immunol. 2010;185(12):7443\u201351. This manuscript provides the first mechanistic evidence for innate responses of eosinophils against colon carcinoma cells.","journal-title":"J Immunol"},{"key":"290_CR96","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1056\/NEJM197402212900802","volume":"290","author":"SI Wasserman","year":"1974","unstructured":"Wasserman SI, Goetzl EJ, Ellman L, Austen KF. Tumor associated eosinophilotactic factor. NEJM. 1974;290:420\u20134.","journal-title":"NEJM"},{"issue":"6","key":"290_CR97","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jaci.2008.04.005","volume":"121","author":"BW Cherry","year":"2008","unstructured":"Cherry BW, Yoon J, Bartemes KR, Iijima K, Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol. 2008;121(6):1484.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"290_CR98","first-page":"437","volume":"48","author":"M Carlson","year":"1993","unstructured":"Carlson M, Peterson C, Venge P. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation. Allergy. 1993;48(6):437\u201342.","journal-title":"Allergy"},{"key":"290_CR99","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.molimm.2006.05.002","volume":"44","author":"RJ Pleass","year":"2007","unstructured":"Pleass RJ, Lang ML, Kerr MA, Woof JM. IgA is a more potent inducer of NADPH oxidase activation and degranulation in blood eosinophils than IgE. Mol Immunol. 2007;44:1401\u20138.","journal-title":"Mol Immunol"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-012-0290-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-012-0290-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-012-0290-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-012-0290-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T15:14:42Z","timestamp":1733152482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-012-0290-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,9]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["290"],"URL":"https:\/\/doi.org\/10.1007\/s11882-012-0290-3","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"type":"print","value":"1529-7322"},{"type":"electronic","value":"1534-6315"}],"subject":[],"published":{"date-parts":[[2012,8,9]]},"assertion":[{"value":"9 August 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}